Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Stéphane Bancel
Person

Stéphane Bancel

Tracked across 2 events · 82 articles · First seen Jan 29, 2026 · Last active Feb 20, 2026

Sentiment
10
Attention
4
Events
2
Relationships
1
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (2)
4 -40
Regulatory
FDA Rejects Moderna's mRNA Flu Vaccine Application
Stéphane Bancel, CEO of Moderna, expressed disappointment with the United States===Food and Drug Administration's decision, stating it was inconsistent with prior communications and did not identify safety or efficacy concerns. He has requested a meeting to discuss the path forward.
Feb 10, 2026 · 69 articles
4 60
Business
Moderna and Recordati Partner on mRNA-3927
As CEO of Moderna, Stéphane Bancel expressed pride in partnering with Recordati, highlighting Recordati's commercial expertise in rare diseases to accelerate the benefit of mRNA-3927.
Jan 29, 2026 · 13 articles
Relationships (1)
Moderna CEO ↔ Stéphane Bancel Stéphane Bancel is the CEO of Moderna.
NEWSDESK
Track Stéphane Bancel live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.